Page last updated: 2024-08-17

quinoxalines and 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine

quinoxalines has been researched along with 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheong, YH; Kaang, BK; Kim, MK; Son, MH	1

Other Studies

1 other study(ies) available for quinoxalines and 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine

Article	Year
Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently. Biochemical and biophysical research communications, 2012, Jan-06, Volume: 417, Issue:1 Topics: Animals; Calcium; CHO Cells; Cricetinae; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Peptides; Pyrimidines; Quinoxalines; Receptors, Glucagon; Sulfones; Venoms	2012

Article

Year

Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.

Biochemical and biophysical research communications, 2012, Jan-06, Volume: 417, Issue:1

Topics: Animals; Calcium; CHO Cells; Cricetinae; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Peptides; Pyrimidines; Quinoxalines; Receptors, Glucagon; Sulfones; Venoms

2012